Cooper Companies

US · COO #1402 by market cap Listed 1970

54.75 -1.68 -2.98%

Live - 5344 symbols - heartbeat 466s ago · 2026-10-08 06:48

Pre-market 54.07 -1.24%

After-hours 55.00 +0.46%

Overnight 54.57 -0.33%

Market cap: 10.41B
P/E (TTM): 18.81
P/B: 1.25
EPS: 1.87
Div yield: 0.00%
52W pos: 10%

Reader sentiment Are you bullish or bearish on COO?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Financial Health how this is computed

Fair

Altman Z-Score is 2.97, in the 1.8-3.0 "grey zone".
Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.

Revenue annual, last 8 years

Latest year +5.06% YoY

Margins

Gross margin: 65.54%
Operating margin: 16.69%
Net margin: 9.16%

Key ratios & quality

Enterprise value: 12.80B
Altman Z-Score: 2.97

Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.

Income statement

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	2.53B	2.65B	2.43B	2.92B	3.31B	3.59B	3.90B	4.09B
Gross profit	1.63B	1.76B	1.53B	1.96B	2.14B	2.36B	2.60B	2.68B
Selling & admin expenses	973.30M	996.20M	992.50M	1.21B	1.34B	1.50B	1.53B	1.63B
Research & development	84.80M	86.70M	93.30M	92.70M	110.30M	137.40M	155.10M	172.20M
Operating profit	427.50M	528.10M	311.80M	505.80M	507.60M	533.10M	705.70M	682.90M
Pretax profit	331.90M	477.40M	266.50M	491.50M	475.30M	412.90M	582.30M	566.50M
Tax	192.00M	10.70M	28.10M	-2.45B	89.50M	118.70M	190.00M	191.60M
Net profit	139.90M	466.70M	238.40M	2.94B	385.80M	294.20M	392.30M	374.90M
Basic EPS	1	2	1	15	2	1	2	2
Diluted EPS	0.70	2.33	1.20	14.79	1.94	1.48	1.96	1.87

Line item	2025-04	2025-07	2025-10	2026-01	2026-04	2026-07
Revenue	1.00B	1.06B	1.07B	1.02B	1.08B	1.07B
Gross profit	679.10M	692.00M	650.80M	695.20M	735.40M	711.90M
Selling & admin expenses	399.00M	421.70M	419.20M	390.20M	676.20M	401.30M
Research & development	45.50M	44.60M	41.40M	44.30M	42.50M	41.60M
Operating profit	184.80M	175.70M	140.40M	212.80M	-31.00M	222.00M
Pretax profit	144.50M	151.90M	116.80M	192.20M	-48.40M	201.80M
Tax	56.80M	53.60M	32.20M	61.40M	29.50M	-231.00M
Net profit	87.70M	98.30M	84.60M	130.80M	-77.90M	432.80M
Basic EPS	0	0	0	1	0	2
Diluted EPS	0.44	0.49	0.43	0.66	-0.40	2.24

Balance sheet

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Total current assets	1.09B	1.16B	1.27B	1.47B	1.53B	1.70B	1.95B	2.11B
Cash & ST investments	77.70M	89.00M	115.90M	95.90M	138.20M	120.80M	107.60M	110.60M
Inventory	468.80M	506.90M	570.40M	585.60M	628.70M	735.60M	802.70M	846.00M
Total assets	6.11B	6.27B	6.74B	9.61B	11.49B	11.66B	12.32B	12.39B
Total current liabilities	536.50M	1.11B	1.00B	732.10M	1.28B	969.00M	1.02B	1.11B
Short-term debt	37.10M	563.70M	442.60M	83.40M	412.60M	45.40M	33.30M	47.80M
Long-term debt	1.99B	1.26B	1.38B	1.40B	2.35B	2.52B	2.55B	2.46B
Total liabilities	2,805,000,000.00	2,645,900,000.00	2,912,700,000.00	2,664,200,000.00	4,317,600,000.00	4,107,900,000.00	4,231,600,000.00	4,155,700,000.00
Total equity	3.31B	3.63B	3.82B	6.94B	7.17B	7.55B	8.08B	8.24B
Retained earnings	2.58B	3.03B	3.26B	6.20B	6.58B	6.88B	7.27B	7.64B

Line item	2025-04	2025-07	2025-10	2026-01	2026-04	2026-07
Total current assets	2.13B	2.14B	2.11B	2.13B	2.30B	2.28B
Cash & ST investments	116.20M	124.90M	110.60M	124.90M	138.80M	154.70M
Inventory	880.30M	881.00M	846.00M	876.40M	896.40M	911.50M
Total assets	12.41B	12.38B	12.39B	12.42B	12.48B	12.67B
Total current liabilities	1.01B	1.01B	1.11B	1.60B	1.80B	1.87B
Short-term debt	59.80M	46.90M	47.80M	620.70M	598.90M	628.10M
Long-term debt	2.52B	2.43B	2.46B	1.88B	1.86B	1.91B
Total liabilities	4,125,500,000.00	4,023,700,000.00	4,155,700,000.00	4,060,200,000.00	4,243,200,000.00	4,345,000,000.00
Total equity	8.29B	8.35B	8.24B	8.36B	8.24B	8.33B
Retained earnings	7.46B	7.56B	7.64B	7.77B	7.70B	8.13B

Cash flow

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Operating cash flow	668.90M	713.20M	486.60M	738.60M	692.40M	607.50M	709.30M	796.10M
Depreciation & amortization	275.10M	280.80M	287.10M	309.30M	346.10M	367.70M	375.10M	377.40M
Free cash flow	475.30M	421.10M	176.20M	524.20M	450.40M	215.00M	288.10M	433.70M
Dividends paid	-2.90M	-3.00M	-3.00M	-3.00M	-3.00M	-3.00M	0	0
Stock buybacks / issuance	0	-156.10M	-47.80M	-24.80M	-78.50M	0	0	-290.10M
Ending cash balance	80.20M	89.50M	116.80M	96.60M	138.60M	120.90M	107.70M	110.60M

Line item	2025-04	2025-07	2025-10	2026-01	2026-04	2026-07
Operating cash flow	96.20M	261.40M	247.90M	260.90M	182.80M	341.70M
Depreciation & amortization	92.60M	95.40M	98.40M	95.50M	95.40M	94.70M
Free cash flow	18.10M	164.50M	149.90M	158.70M	96.40M	273.00M
Dividends paid	--	--	--	--	--	--
Stock buybacks / issuance	-40.60M	-52.70M	-196.80M	-92.50M	-15.50M	-339.20M
Ending cash balance	116.20M	124.90M	110.60M	125.00M	139.00M	154.90M

Returns & efficiency

Line item	2018	2019	2020	2021	2022	2023	2024	2025
ROE %	4.32	13.46	6.40	54.70	5.47	4.00	5.02	4.59
ROA %	2.55	7.54	3.66	36.03	3.66	2.54	3.27	3.03
ROIC %	4.14	9.89	4.78	40.64	4.64	3.68	4.52	4.12
5-year avg ROE %	9.17	9.69	9.42	18.31	16.87	16.80	15.12	14.76
EBIT margin %	16.37	20.55	12.48	17.61	16.10	14.42	17.88	16.29
FCF / sales %	18.77	15.87	7.25	17.94	13.61	5.98	7.40	10.60
Current ratio	2.03	1.05	1.27	2.00	1.20	1.76	1.91	1.89
Quick ratio	0.84	0.47	0.55	0.83	0.54	0.75	0.81	0.84
Debt / assets	33.09	29.11	30.62	15.42	24.05	22.04	20.98	20.21
LT debt / equity	60.03	34.80	42.38	20.13	32.77	33.42	31.55	29.83
Interest coverage	5.01	8.02	8.24	22.28	9.29	4.92	6.09	6.67
Revenue CAGR (3Y) %	12.12	10.50	4.36	4.89	7.63	13.91	10.05	7.35
Net income CAGR (3Y) %	-11.74	19.44	-13.85	176.11	-6.15	7.26	-48.93	-0.95
FCF CAGR (3Y) %	47.57	5.66	-27.71	3.32	2.27	6.86	-18.09	-1.25

Line item	2025-04	2025-07	2025-10	2026-01	2026-04	2026-07
ROE %	5.15	5.01	4.59	4.87	2.85	6.84
ROA %	3.39	3.33	3.03	3.26	1.89	4.55
ROIC %	4.52	4.45	4.12	4.32	2.70	5.75
5-year avg ROE %	--	--	--	--	--	--
EBIT margin %	18.45	17.82	16.29	16.90	11.95	13.02
FCF / sales %	9.17	10.18	10.60	11.83	13.46	16.00
Current ratio	2.10	2.12	1.89	1.34	1.27	1.22
Quick ratio	0.89	0.91	0.84	0.58	0.53	0.51
Debt / assets	20.83	20.02	20.21	20.12	19.71	20.08
LT debt / equity	30.47	29.11	29.83	22.47	22.59	23.01
Interest coverage	6.96	7.03	6.67	7.28	5.43	6.18
Revenue CAGR (3Y) %	--	--	--	--	--	--
Net income CAGR (3Y) %	--	--	--	--	--	--
FCF CAGR (3Y) %	--	--	--	--	--	--

✦ Quant Revenue Concentration how this is computed

Lead segment, long tail

CooperVision is the largest reported line at 67.25% of revenue, across 2 reported segments.
CooperSurgical follows at 32.75%, so the top line still matters most but isn’t the whole story.

Revenue breakdown most recent period

Business

CooperVision67.25%

CooperSurgical32.75%

Quote time 2026-10-08 06:48:45 · For reference only, not investment advice and not tailored to your situation.